Michael Flanagan W.'s most recent trade in Avidity Biosciences Inc was a trade of 3,976 Common Stock done at an average price of $72.4 . Disclosure was reported to the exchange on Jan. 21, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 72.45 per share. | 21 Jan 2026 | 3,976 | 87,651 | - | 72.4 | 288,061 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 72.45 per share. | 21 Jan 2026 | 2,558 | 85,093 | - | 72.4 | 185,327 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 72.23 per share. | 07 Jan 2026 | 2,373 | 91,627 | - | 72.2 | 171,402 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 27,500 | 107,695 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.87 per share. | 17 Dec 2025 | 13,695 | 94,000 | - | 71.9 | 984,260 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 38.94 per share. | 11 Sep 2025 | 20,000 | 80,195 | - | 38.9 | 778,702 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2025 | 20,000 | 76,500 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.22 per share. | 11 Sep 2025 | 20,000 | 100,195 | - | 14.2 | 284,400 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.22 per share. | 11 Jun 2025 | 20,000 | 100,195 | - | 14.2 | 284,400 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2025 | 20,000 | 96,500 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 32.88 per share. | 11 Jun 2025 | 20,000 | 80,195 | - | 32.9 | 657,694 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 31.06 per share. | 20 Mar 2025 | 11,780 | 80,195 | - | 31.1 | 365,868 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2025 | 20,000 | 116,500 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 30.13 per share. | 11 Mar 2025 | 20,000 | 91,975 | - | 30.1 | 602,614 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.22 per share. | 11 Mar 2025 | 20,000 | 111,975 | - | 14.2 | 284,400 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.60 per share. | 21 Jan 2025 | 3,860 | 93,787 | - | 28.6 | 110,383 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.59 per share. | 21 Jan 2025 | 1,812 | 91,975 | - | 28.6 | 51,809 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 25,000 | 97,647 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | Flanagan Michael W. | CSTO | Sale of securities on an exchange or to another person at price $ 32.66 per share. | 18 Dec 2024 | 12,742 | 72,647 | - | 32.7 | 416,154 | Common Stock |
| Avidity Biosciences Inc | Flanagan Michael W. | CSTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 24,000 | 86,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | W. Flanagan Michael | CSTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.47 per share. | 11 Dec 2024 | 24,000 | 109,389 | - | 22.5 | 539,280 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Sale of securities on an exchange or to another person at price $ 35.77 per share. | 11 Dec 2024 | 24,000 | 85,389 | - | 35.8 | 858,401 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.75 per share. | 01 Oct 2024 | 62,500 | 147,889 | - | 26.8 | 1,671,875 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 62,500 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Sale of securities on an exchange or to another person at price $ 47.62 per share. | 01 Oct 2024 | 62,500 | 85,389 | - | 47.6 | 2,976,113 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2024 | 25,000 | 97,718 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2024 | 25,000 | 85,871 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Sale of securities on an exchange or to another person at price $ 44.00 per share. | 19 Sep 2024 | 13,153 | 72,718 | - | 44.0 | 578,737 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Sale of securities on an exchange or to another person at price $ 43.89 per share. | 19 Sep 2024 | 11,847 | 85,389 | - | 43.9 | 519,996 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.75 per share. | 11 Sep 2024 | 62,500 | 138,265 | - | 26.8 | 1,671,875 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 62,500 | 87,500 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Sale of securities on an exchange or to another person at price $ 40.40 per share. | 11 Sep 2024 | 62,500 | 75,765 | - | 40.4 | 2,525,013 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 34,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Sale of securities on an exchange or to another person at price $ 40.40 per share. | 11 Sep 2024 | 34,000 | 75,765 | - | 40.4 | 1,373,556 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.47 per share. | 11 Sep 2024 | 34,000 | 109,765 | - | 22.5 | 763,980 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Sale of securities on an exchange or to another person at price $ 40.40 per share. | 11 Sep 2024 | 14,894 | 60,871 | - | 40.4 | 601,676 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 25,000 | 75,765 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 25,000 | 60,871 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Sale of securities on an exchange or to another person at price $ 39.13 per share. | 17 Jun 2024 | 10,106 | 50,765 | - | 39.1 | 395,445 | Common Stock |
| Avidity Biosciences Inc | Michael Flanagan W. | CSTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2024 | 88,000 | 88,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Flanagan Michael W. | CSTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2024 | 20,000 | 20,290 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | W. Flanagan Michael | CSTO | Sale of securities on an exchange or to another person at price $ 10.13 per share. | 20 Jan 2024 | 4,129 | 35,871 | - | 10.1 | 41,827 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 144,000 | 144,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 40,000 | 40,290 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2022 | 136,500 | 136,500 | - | - | Stock Option (Right to Buy) |